Neuropharmacology

Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means.

Publisher
Elsevier
Website
http://www.journals.elsevier.com/neuropharmacology/
Impact factor
4.137 (2011)

Some content from Wikipedia, licensed under CC BY-SA

Psychology & Psychiatry

Common antidepressant sertraline may change brain structures

A commonly prescribed antidepressant may alter brain structures in depressed and non-depressed individuals in very different ways, according to new research at Wake Forest Baptist Medical Center.

Medications

Reclassification recommendations for drug in 'magic mushrooms'

In an evaluation of the safety and abuse research on the drug in hallucinogenic mushrooms, Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule ...

Neuroscience

Brain changed by caffeine in utero, study finds

New research finds caffeine consumed during pregnancy can change important brain pathways that could lead to behavioral problems later in life. Researchers in the Del Monte Institute for Neuroscience at the University of ...

Medications

Scientists reveal ADHD medication's effect on the brain

Attention-deficit hyperactivity disorder (ADHD) is a neurobiological disorder characterized by symptoms of hyperactivity, inattention and impulsivity. People with the condition are often prescribed a stimulant drug called ...

Medications

Non-psychotropic cannabinoids show promise for pain relief

Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Neuroscience

Neuroscientists discover why exercise reduces stress

On top of the many reasons to hit the gym, working out may also improve the ability to persevere through hard times. In a series of recent experiments, neuroscientists at the University of Georgia have begun to unravel the ...

Neuroscience

Researchers uncover new target of alcohol in the brain

When alcohol enters the brain, it causes neurons in a specialized region called the ventral tegmental area, or VTA—also known as the "pleasure center"—to release dopamine, a neurotransmitter that produces those feel-good ...

page 1 from 6